Repare Therapeutics Inc.
RPTX
$2.12
-$0.01-0.24%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4,548.00% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4,548.00% | -- | |||
| Cost of Revenue | -47.48% | -29.54% | |||
| Gross Profit | 129.35% | 30.77% | |||
| SG&A Expenses | -24.56% | -21.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -40.68% | -27.25% | |||
| Operating Income | 97.86% | 28.15% | |||
| Income Before Tax | 120.63% | 44.41% | |||
| Income Tax Expenses | -41.53% | -32.97% | |||
| Earnings from Continuing Operations | 119.46% | 44.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 119.46% | 44.27% | |||
| EBIT | 97.86% | 28.15% | |||
| EBITDA | 98.12% | 28.84% | |||
| EPS Basic | 119.43% | 44.70% | |||
| Normalized Basic EPS | 109.80% | 29.45% | |||
| EPS Diluted | 119.43% | 45.06% | |||
| Normalized Diluted EPS | 109.77% | 29.45% | |||
| Average Basic Shares Outstanding | 0.10% | 0.78% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||